These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 25523282)

  • 1. Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.
    Rouha H; Badarau A; Visram ZC; Battles MB; Prinz B; Magyarics Z; Nagy G; Mirkina I; Stulik L; Zerbs M; Jägerhofer M; Maierhofer B; Teubenbacher A; Dolezilkova I; Gross K; Banerjee S; Zauner G; Malafa S; Zmajkovic J; Maier S; Mabry R; Krauland E; Wittrup KD; Gerngross TU; Nagy E
    MAbs; 2015; 7(1):243-54. PubMed ID: 25523282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin.
    Diep BA; Le VT; Visram ZC; Rouha H; Stulik L; Dip EC; Nagy G; Nagy E
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6333-40. PubMed ID: 27527081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disarming Staphylococcus aureus from destroying human cells by simultaneously neutralizing six cytotoxins with two human monoclonal antibodies.
    Rouha H; Weber S; Janesch P; Maierhofer B; Gross K; Dolezilkova I; Mirkina I; Visram ZC; Malafa S; Stulik L; Badarau A; Nagy E
    Virulence; 2018 Jan; 9(1):231-247. PubMed ID: 29099326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic landscapes on
    Kailasan S; Kant R; Noonan-Shueh M; Kanipakala T; Liao G; Shulenin S; Leung DW; Alm RA; Adhikari RP; Amarasinghe GK; Gross ML; Aman MJ
    MAbs; 2022; 14(1):2083467. PubMed ID: 35730685
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of Combination Vaccine Conferring Optimal Protection against Six Pore-Forming Toxins of Staphylococcus aureus.
    Zhang Q; Jiang T; Mao X; Kim JD; Ahn DH; Jung Y; Bae T; Lee BL
    Infect Immun; 2021 Sep; 89(10):e0034221. PubMed ID: 34227839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergent Evolution of Neutralizing Antibodies to Staphylococcus aureus γ-Hemolysin C That Recognize an Immunodominant Primary Sequence-Dependent B-Cell Epitope.
    Hernandez DN; Tam K; Shopsin B; Radke EE; Law K; Cardozo T; Torres VJ; Silverman GJ
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546616
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective Efficacy of Monoclonal Antibodies Neutralizing Alpha-Hemolysin and Bicomponent Leukocidins in a Rabbit Model of Staphylococcus aureus Necrotizing Pneumonia.
    Vu TTT; Nguyen NTQ; Tran VG; Gras E; Mao Y; Jung DH; Tkaczyk C; Sellman BR; Diep BA
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844012
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure and Function of the Two-Component Cytotoxins of Staphylococcus aureus - Learnings for Designing Novel Therapeutics.
    Badarau A; Trstenjak N; Nagy E
    Adv Exp Med Biol; 2017; 966():15-35. PubMed ID: 28455832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH.
    Badarau A; Rouha H; Malafa S; Logan DT; Håkansson M; Stulik L; Dolezilkova I; Teubenbacher A; Gross K; Maierhofer B; Weber S; Jägerhofer M; Hoffman D; Nagy E
    J Biol Chem; 2015 Jan; 290(1):142-56. PubMed ID: 25371205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel human monoclonal antibodies targeting the F subunit of leukocidins reduce disease progression and mortality caused by Staphylococcus aureus.
    Jing C; Liu C; Liu F; Gao Y; Liu Y; Guan Z; Xuan B; Yu Y; Yang G
    BMC Microbiol; 2018 Nov; 18(1):181. PubMed ID: 30419818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors.
    Spaan AN; Schiepers A; de Haas CJ; van Hooijdonk DD; Badiou C; Contamin H; Vandenesch F; Lina G; Gerard NP; Gerard C; van Kessel KP; Henry T; van Strijp JA
    J Immunol; 2015 Aug; 195(3):1034-43. PubMed ID: 26091719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.
    Karauzum H; Adhikari RP; Sarwar J; Devi VS; Abaandou L; Haudenschild C; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Warfield KL; Shulenin S; Aman MJ
    PLoS One; 2013; 8(6):e65384. PubMed ID: 23762356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies neutralizing alpha-hemolysin, bicomponent leukocidins, and clumping factor A protected against
    Nguyen NTQ; Doan TNM; Sato K; Tkaczyk C; Sellman BR; Diep BA
    Front Immunol; 2023; 14():1260627. PubMed ID: 37781371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
    Adhikari RP; Kort T; Shulenin S; Kanipakala T; Ganjbaksh N; Roghmann MC; Holtsberg FW; Aman MJ
    PLoS One; 2015; 10(9):e0137874. PubMed ID: 26367030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Context matters: The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies.
    Badarau A; Rouha H; Malafa S; Battles MB; Walker L; Nielson N; Dolezilkova I; Teubenbacher A; Banerjee S; Maierhofer B; Weber S; Stulik L; Logan DT; Welin M; Mirkina I; Pleban C; Zauner G; Gross K; Jägerhofer M; Magyarics Z; Nagy E
    MAbs; 2016 Oct; 8(7):1347-1360. PubMed ID: 27467113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcal γ-hemolysins induce IL-4 production in murine basophils.
    Ogata A; Hayashi K; Kitano T; Onozaki K; Itoh S; Hida S
    Biochem Biophys Res Commun; 2022 Dec; 632():107-112. PubMed ID: 36206594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing lung pathology and mortality in rabbit Staphylococcus aureus pneumonia models with cytotoxin-neutralizing monoclonal IgGs penetrating the epithelial lining fluid.
    Stulik L; Rouha H; Labrousse D; Visram ZC; Badarau A; Maierhofer B; Groß K; Weber S; Kramarić MD; Glojnarić I; Nagy G; Croisier D; Nagy E
    Sci Rep; 2019 Mar; 9(1):5339. PubMed ID: 30926865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The two Staphylococcal bi-component toxins, leukocidin and gamma-hemolysin, share one component in common.
    Kamio Y; Rahman A; Nariya H; Ozawa T; Izaki K
    FEBS Lett; 1993 Apr; 321(1):15-8. PubMed ID: 8467905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology of the pore-forming cytolysins from Staphylococcus aureus, alpha- and gamma-hemolysins and leukocidin.
    Tomita T; Kamio Y
    Biosci Biotechnol Biochem; 1997 Apr; 61(4):565-72. PubMed ID: 9145511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.
    Sharma-Kuinkel BK; Wu Y; Tabor DE; Mok H; Sellman BR; Jenkins A; Yu L; Jafri HS; Rude TH; Ruffin F; Schell WA; Park LP; Yan Q; Thaden JT; Messina JA; Fowler VG; Esser MT
    J Clin Microbiol; 2015 Jan; 53(1):227-36. PubMed ID: 25392350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.